Literature DB >> 3297735

The majority of "natural" immunoglobulin-secreting cells are short-lived and the progeny of cycling lymphocytes.

M Lévy, P Vieira, A Coutinho, A Freitas.   

Abstract

Treatment of mice with hydroxyurea to selectively kill all cycling cells has been used to study population dynamics and life expectancy of "natural" immunoglobulin-secreting cells in the bone marrow and spleen of nonimmunized animals. The results show that 50 to 90% of those cells are eliminated 2 to 3 days after one cycle of hydroxyurea administration, demonstrating their recent origin from cycling precursors. Using a protocol of long-term hydroxyurea treatment which abrogates cell production from the cycling precursors compartments, it was shown that "natural" immunoglobulin-secreting cells have a very short half renewal time, in the range of 15-60 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297735     DOI: 10.1002/eji.1830170618

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Modeling immune reactivity in secondary lymphoid organs.

Authors:  A S Perelson; G Weisbuch
Journal:  Bull Math Biol       Date:  1992-07       Impact factor: 1.758

Review 2.  What is and what should always have been: long-lived plasma cells induced by T cell-independent antigens.

Authors:  Alexandra Bortnick; David Allman
Journal:  J Immunol       Date:  2013-06-15       Impact factor: 5.422

3.  Human immune memory to yellow fever and smallpox vaccination.

Authors:  Jens Wrammert; Joe Miller; Rama Akondy; Rafi Ahmed
Journal:  J Clin Immunol       Date:  2008-12-04       Impact factor: 8.317

4.  A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.

Authors:  Courtney L Davis; Rezwanul Wahid; Franklin R Toapanta; Jakub K Simon; Marcelo B Sztein
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 5.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

6.  Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics.

Authors:  Courtney L Davis; Rezwanul Wahid; Franklin R Toapanta; Jakub K Simon; Marcelo B Sztein; Doron Levy
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.